HAS-BLED outperforms other predictors of bleeding

In this large cohort of anticoagulated Afib patients, HAS-BLED performed the best in predicting clinically relevant bleeding, compared to HEMORR2HAGES or ATRIA, with receiver-operating characteristic (ROC) scores of 0.60, 0.55, and 0.50 respectively. HAS-BLED is the best to date risk score for predicting bleeding in anticoagulated Afib patients (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment